Estimating The Impact Associated To The Use Omalizumab In The Treatment of Severe Persistent Allergic Asthma In Portugal – Evaluating Outcomes And Treatment Costs Using Real World Data From Portuguese Patients

Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1209
https://www.valueinhealthjournal.com/article/S1098-3015(16)32575-X/fulltext
Section Title : Disease-Specific Studies
Section Order : 1131
First Page : A555
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32575-X&doi=10.1016/j.jval.2016.09.1209
HEOR Topics :
Tags :
Regions :